| Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey P Dunscombe, C Grau, N Defourny, J Malicki, JM Borras, M Coffey, ... Radiotherapy and Oncology 112 (2), 165-177, 2014 | 90 | 2014 |
| Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate IC Brie, O Soritau, N Dirzu, C Berce, A Vulpoi, C Popa, M Todea, S Simon, ... Journal of biological engineering 8, 1-19, 2014 | 47 | 2014 |
| Radiotherapy utilization in developing countries: An IAEA study E Rosenblatt, E Fidarova, EH Zubizarreta, MB Barton, GW Jones, ... Radiotherapy and oncology 128 (3), 400-405, 2018 | 45 | 2018 |
| Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data CV Chiorean R, Berindan-Neagoe I, Braicu C, Florian IS, Leucuta D, Crisan D Cancer Biomarkers : Section A of Disease Markers 14 (2-3), 185-194, 2014 | 43 | 2014 |
| Optimal radiotherapy utilisation rate in developing countries: An IAEA study E Rosenblatt, M Barton, W Mackillop, E Fidarova, L Cordero, J Yarney, ... Radiotherapy and Oncology 116 (1), 35-37, 2015 | 38 | 2015 |
| Porous cp titanium using dextrin as space holder for endosseous implants I Gligor, O Soritau, M Todea, C Berce, A Vulpoi, T Marcu, V Cernea, ... Particulate Science and Technology 31 (4), 357-365, 2013 | 27 | 2013 |
| Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines P Virag, M Perde-Schrepler, E Fischer-Fodor, C Tatomir, SA Dorneanu, ... Anti-cancer drugs 23 (10), 1032-1038, 2012 | 24 | 2012 |
| Antiproliferative effect and genotoxicity of novel synthesized palladium complexes with organoarsenic ligands N Miklášová, E Fischer-Fodor, P Lönnecke, MP Schrepler, P Virag, ... Journal of inorganic biochemistry 103 (12), 1739-1747, 2009 | 24 | 2009 |
| Comparative study of two evaluation methods for the genotoxic effects of environmental heavy metals on normal cells P Virag, I Brie, ID Postescu, M Perde-Schrepler, E Fischer-Fodor, ... Toxicology and Industrial Health 25 (4-5), 253-258, 2009 | 14 | 2009 |
| Radiation therapy utilization in middle-income countries E Rosenblatt, E Fidarova, E Zubizarreta, MB Barton, W MacKillop, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), S37, 2016 | 7 | 2016 |
| Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma C Ordeanu, O Coza, S Gavris, N Todor, E Szilagy, M Bako, V Cernea, ... JOURNAL-BALKAN UNION OF ONCOLOGY 12 (2), 221, 2007 | 4 | 2007 |
| Relationship between tumor cells’ in vitro radiosensitivity measured by comet assay and clinical response to radiotherapy of cervix carcinomas I Brie, M Perde, P Virág, E Fischer, O Soritau, ID Postescu, V Nagy, ... Radioterapie & Oncologie Medicala 2, 96-105, 2005 | 4 | 2005 |
| From Passive to Active in the Design of External Radiotherapy Database at Oncology Institute" Prof. Dr. Ion Chiricuţă" from Cluj-Napoca N Todor, VI Cernea, C Aurel Applied Medical Informatics 25 (3, 4), 7-15, 2009 | 2 | 2009 |
| The Effect of a Grape Seed Extract on Radiation‐Induced DNA Damage in Human Lymphocytes T Dicu, ID Postescu, V Foriş, I Brie, E Fischer‐Fodor, V Cernea, ... AIP Conference Proceedings 1131 (1), 181-186, 2009 | 1 | 2009 |
| Genotoxic effects of 60Co gamma-rays on Chinese hamster ovary (CHO) cells T Dicu, I Brie, P Virag, E Fischer, M Perde, V Foriş, V Cernea, C Cosma Nukleonika 53, 161-165, 2008 | 1 | 2008 |
| Outcomes and prognostic factors for angiosarcoma: A 19-year single institution experience ME Chirila, DT Eniu, N Todor, VM Nagy, ML Galatir, D Coza, V Cernea, ... Annals of Oncology 29, viii592, 2018 | | 2018 |
| OC-0192: Optimal radiotherapy utilization rate in developing countries: an IAEA study E Rosenblatt, M Barton, W Mackillop, E Fidarova, L Cordero, J Yarney, ... Radiotherapy and Oncology, S96-S97, 2015 | | 2015 |
| P13. 05SECOND RADIOTHERAPY TREATMENT IN RECURRENT BRAIN TUMORS DM Cernea, S Halasag, R Stahiescu, N Todor, S Florian, VI Cernea Neuro-oncology 16 (Suppl 2), ii66, 2014 | | 2014 |
| P17. 16PRIMARY CENTRAL NERVOUS SYSTEM TUMORS IN YOUNG ADULTS: PATHOLOGY AND TREATMENT RESULTS DM Cernea, S Halasag, R Stahiescu, N Todor, S Florian, VI Cernea Neuro-oncology 16 (Suppl 2), ii90, 2014 | | 2014 |
| DNA DAMAGE INDUCED BY PLATINUM-BASED DRUGS AS MARKER FOR IN VITRO SENSITIVITY OF COLORECTAL CANCER CELLS P Virag, M Perde-Schrepler, E Fischer-Fodor, I Brie, C Tatomir, A Chis, ... ANNALS OF ONCOLOGY 22, v111-v111, 2011 | | 2011 |
joel yarneyKorle bu Teaching Hospital and University of Cape Coast在 kbth.gov.gh 的电子邮件经过验证
